In order to carry out the “New Bamboos” plan, Bright Stone innovation Investment Group Co. LTD takes a stake purchase Yantai Hongyuan Oxygen Industry Group Co. Ltd’s 75% of equity, which is priced at 360 million RMB. Bright Stone has acquired another “Innovative Little Giants in Technology”.
Yantai Hongyuan Oxygen Industry Group Co. Ltd is the industry leader in hyperbaric oxygen chamber. Hongyuan is the only corporation in the industry that is able to manufacture high quality hyperbaric oxygen chamber within the industry in high quantities, and is able to provide for medical, military and construction devices. Furthermore, Hongyuan is the only company in China that designs and manufactures hyperbaric intervention for Tunnel Boring Machine. Furthermore, Hongyuan is capable of design and manufacture A5 manned pressure vessel, and is approved for weapon equipment system and ASME. Hongyuan has worked with the Fourth Military Medical University and School of Aerospace medicine to research and manufacture pressure and temperature compound explosion decompression chamber. Hongyuan has also worked with National Aerospace Laboratory to build Shenzhou series of simulation return chamber for aerospace experiment. On top of research, Hongyuan also extend their products to tourism. Hongyuan worked with China Shipbuilding Industry Corporation to build tourism submarine with transparent organic glass, and the first generation of product “Huandao Dragon No.1” has been used in the market.
Hongyuan manufactures all types of hyperbaric oxygen products, which could be used in diversified fields, such as medical institutions, marine rescue, emergency response, aerospace medical research and high altitude oxygen inhalation support equipment. Hongyuan’s products have been sold to countries such as Turkey, Israel, Singapore and Argentina. Up to now, Hongyuan has the market shares of 60% for providing hyperbaric oxygen chambers for hospitals and medical institutions, 90% market shares for marine fleets, bases and rescue teams’ all kinds of decompression chambers, 80% of market shares in construction fields for intervention chambers and rescue chambers for enterprises such as China Railway Construction Corporation and China Railway Engineering Group.
As China’s policy shifts toward big health industry, Bright Stone intends to use Hongyuan as a platform in the health field to integrate medical and health care industry’s resources. Bright Stone will kept invest into Hongyuan’s research, manufacturing and products to ensure Hongyuan could develop vertically and horizontally in the field.
Bright Stone will keep promoting its “direct investment + investment management” model and invest into more “Innovative Little Giants in Technology” through direct investment.